The landscape of dementia diagnosis has advanced radically with the appearance of complex biomarkers, like amyloid PET scans, tau imaging, and blood-primarily based checks that could detect Alzheimer's pathology a long time before signs or symptoms emerge. While these technological advancements signify extraordinary progress in understanding neurodegenerative disorders, they've not https://neuropsychological-testin99887.bloggosite.com/45524638/the-enduring-price-of-cognitive-evaluation-for-older-older-people